{
  "docId": "019dd923-622c-750b-8b9b-7e7228555e88",
  "docSlug": "36c903ba19aa",
  "documentTitle": "Allergan, Inc. (AGN)",
  "authorId": "01_Pershing_Square",
  "authorName": "William Ackman",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2014-04-22 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.70665085,
  "pageNumber": 9,
  "pageCount": 110,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "villain_critique",
  "function": "name_villain",
  "density": "sparse",
  "nDataPoints": 0,
  "notes": "The slide uses a red callout box to emphasize the core thesis and red 'X' icons to list specific industry pain points.",
  "elementsJson": [
    "headline_text",
    "callout_box",
    "bullet_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/9",
  "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.07,
        "w": 0.82,
        "x": 0.09,
        "y": 0.14
      },
      "kind": "callout",
      "text": "The traditional pharmaceutical company's products are not durable, and growth is not predictable",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "991e6247-6137-48bf-bef9-10296073079e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "The traditional pharmaceutical company’s products are not durable, and growth is not predictable",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-f5d3-71df-9940-6eeacf431a68",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.75,
        "x": 0.12,
        "y": 0.23
      },
      "kind": "list",
      "text": "Patent cliffs for major products; Huge investments in high-risk, low-return R&D to replace off-patent drugs; Price pressure in many segments; Bloated overhead and cost structures; Value-destroying acquisitions",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e18c2fd8-e1c9-4ae7-9fc4-6ad69d8356f4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.7,
        "x": 0.09,
        "y": 0.75
      },
      "kind": "title",
      "text": "We Have Not Previously Invested in a Pharmaceutical Company",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "83d5567e-74d1-4766-a00c-140e989e2f69",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Villain slide",
      "slug": "villain-slide",
      "agent": null,
      "layer": "slide",
      "matchId": "d1adc60c-f25e-49e3-84f9-de36c13f41ac",
      "evidence": "The traditional pharmaceutical company’s products are not durable, and growth is not predictable",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "antagonist-introduction",
      "slug": null,
      "matchId": "aea8deb7-8b90-4c5f-b3f2-8f2a7b97f23b",
      "evidence": "The slide frames the entire pharmaceutical industry as a 'villain' or poor investment target due to structural flaws.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}